Completed

NCT Number: NCT03641599

Right Ventricular Function in Heart Failure

Only a few studies evaluated the RV systolic function in the three categories of HF, regarding the importance of understanding changes in RV function on clinical presentation and outcome; it was essential to understand the prevalence and severity of RV dysfunction among the three groups and the degree of correlation between RV with LV systolic function.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Assessment of the RV Function in Patients With Heart Faliure

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Adult patients of both gender who have the followiong criteria :

(i) symptoms with or without signs of HF (ii) elevated natriuretic peptides (BNP ≥35pg/ mL or NT-proBNP≥125pg/mL) (iii) relevant structural heart disease: left ventricle hypertrophy (left ventricular mass index ≥115 g/m2 for males and ≥95 g/m2 for females) or left atrial enlargement (>34 mL/m2) or diastolic dysfunction (E/e'≥13 and a mean e' septal and lateral wall <9 cm/s) were included.

Then patients were classified according to EF into HFpEF>50%, HFrEF<40% and HFmrEF >40% and <50%

Exclusion criteria

Patients with chronic obstructive pulmonary disease history of pulmonary embolism patients with respiratory failure

Treatment and study plan

Echocardiography

Diagnostic Test

echocardiographic assessment of the RV and LV systolic function

Primary outcomes

assessment of the RV systolic dysfunction in patients with heart failure

Time frame: 1.5 year

degree and prevalence of the RV systolic dysfunction in patients with heart failure with preserved, mid-range and decreased ejection fraction

Sponsors and collaborators

Lead sponsor

shaimaa Mostafa

Other

Registry information

Official study title

Assessment Right Ventricular Systolic Function in Heart Failure With Preserved, Reduced and Mid-range Ejection Fraction

Important dates

Study start: 2017
Primary completion: 2018
Study completion: 2018
First posted: Aug 22, 2018
Registry last updated: Aug 22, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.